IgA and Reproductive Tract Immunity

  • Charu Kaushic
  • Charles R. Wira

Mucosal epithelia line the interior surfaces of the body and account for roughly 75%of the human body’s interface with the environment. The gastrointestinal, respiratory, urinary, and reproductive tracts are all components of the mucosal system. Although each of these tracts serves unique physiological functions, they are also part of a distinct network comprising the common mucosal immune system (Mestecky, 2005a). The combination of physiological functions and external environment drive the immune system at each mucosal surface to make unique and distinct adaptations. For example, the repertoire of commensal organisms typically present on a mucosal surface and pathogenic organisms capable of invading that mucosal barrier are quite


Human Immunodeficiency Virus Genital Tract Simian Immunodeficiency Virus Reproductive Tract Female Reproductive Tract 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexander, N. J., and Anderson, D. J. (1987). Immunology of semen. Fertil. Steril. 47:192–205.PubMedGoogle Scholar
  2. Alfsen, A., Iniguez, P., Bouguyon, E., and Bomsel, M. (2001). Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J. Immunol. 166:6257–6265.PubMedGoogle Scholar
  3. Anderson, D. J., and Pudney, J. (2005). Human male genital tract immunity and experimental models. In: Mestecky, J., Bienenstock, J., Lamm, M., Strober, W., McGhee, J. and Mayer, L. (eds.), Mucosal Immunology, 3rd ed., Academic Press, San Diego, pp. 1647–1659.Google Scholar
  4. Ashkar, A. A., Bauer, S. Mitchell, W. J., Vieira, J., and Rosenthal, K. L. (2003). Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 77:8948–8956.PubMedGoogle Scholar
  5. Ashley, R. L., Corey, L., Dalessio, J., Wilson, P., Remington, M., Barnum, G., and Trethewey, P. (1994). Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections. J. Infect. Dis. 170:20–26.PubMedGoogle Scholar
  6. Belec, L., Georges, A. J., Steenman, G., and Martin, P. M. (1989). Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J Infect. Dis. 160:385–391.PubMedGoogle Scholar
  7. Bell, E. B., and Wolf, B. (1967). Antibody synthesis in vitro by the rabbit vagina against diphtheria toxoid. Nature 214:423–424.PubMedGoogle Scholar
  8. Bhardwaj, N., and Walker, B. D. (2003). Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine. Nat. Med. 9:13–14.PubMedGoogle Scholar
  9. Bjercke, S., and Brandtzaeg, P. (1993). Glandular distribution of immunoglobulins, J chain, secretory component and HLA-DR in the human endometrium throughout the menstrual cycle. Hum. Reprod. 8:1420–1425.PubMedGoogle Scholar
  10. Bolan, G., Ehrhardt, A. A., and Wasserheit, J. N. (1999). Gender perspectives and STDs. In: Holmes, K. K., Sparling, P. F., Mardh, P. A., Stamm, W. E., Piot, P., and Wasserheit, J. N. (eds.), Sexually Transmitted Diseases, 3rd ed., McGraw-Hill, New York, pp. 117–127.Google Scholar
  11. Bomsel, M., Heyman, M., Hocini, H., Lagaye, S., Belec, L., Dupont, C., and Desgranges, C. (1998). Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 9:277–287.PubMedGoogle Scholar
  12. Bomsel, M., Pastori, C., Tudor, D., Alberti, C., Garcia, S., Ferrari, D., Lazzarin, A., and Lopalco, L. (2007). Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells. AIDS 21:13–22.PubMedGoogle Scholar
  13. Brandtzaeg, P. (1981). Transport models for secretory IgA and IgM. Clin. Exp. Immun. 44:221–232.PubMedGoogle Scholar
  14. Brandtzaeg, P. (1997). Mucosal immunity in the female genital tract. J. Reprod. Immunol. 36:23–50.PubMedGoogle Scholar
  15. Brandtzaeg, P. (2003). Role of secretory antibodies in defence against infections. Int. J. Med. Microbiol. 293:3–15.PubMedGoogle Scholar
  16. Brandtzaeg, P., Farstad, I., and Haraldsen, G. (1999). Regional specialization in the mucosal immune system: Primed cells do not always home along the same tract. Immunol. Today 20:267–277.PubMedGoogle Scholar
  17. Brandtzaeg, P., and Johansen, F.-E. (2005). Mucosal B cells: Phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 206:32–63.PubMedGoogle Scholar
  18. Brenchley, J., Price, D, and Douek, D. (2006). HIV disease: Fallout from a mucosal catastrophe? Nat. Immunol. 7:235–239.PubMedGoogle Scholar
  19. Brunham, R. C., Kuo, C. C., Cles, L., and Holmes, K. K. (1983). Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect. Immun. 39:1491–1494.PubMedGoogle Scholar
  20. Buchacz, K., Parekh, B. S., Padian, N. S., van der Straten, A., Phillips, S., Jonte, J., and Holmberg, S. D. (2001). HIV-specific IgG in cervicovaginal secretions of exposed HIV-uninfected female sexual partners of HIV-infected men. AIDS Res. Hum. Retroviruses 17:1689–1693.PubMedGoogle Scholar
  21. Burns, J. W., Siadat-Pajouh, M., Krishnaney, A. A., and Greenberg, H. B. (1996). Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272:104–107.PubMedGoogle Scholar
  22. Burton, D. R. (2002). Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2:706–713.PubMedGoogle Scholar
  23. Canning, M., and Billington, W. (1983). Hormonal regulation of immunoglobulin and plasma cells in the mouse uterus. J. Endocrinol. 97:419–424.PubMedGoogle Scholar
  24. Clerici, M., Barassi, C., Devito, C., Pastori, C., Piconi, S., Trabattoni, D., Longhi, R., Hinkula, J., Broliden, K., and Lopalco, L. (2002). Serum IgA of HIV-exposed uninfected individuals inhibits HIV through recognition of a region within the S-helix of gp41. AIDS 16:1731–1741.PubMedGoogle Scholar
  25. Corey, L., and Wald, A. (1999). Genital herpes. In: Holmes, K. K., Sparling, P. F., Mardh, P. A., Stamm, W. E., Piot, P., and Wasserheit, J. N. (eds.), Sexually Transmitted Diseases, 3rd ed., McGraw-Hill, New York, pp. 285–312.Google Scholar
  26. Crago, S. S., Kutteh, W. H., Moro, I., Allansmith, M. R., Radl, J., Haaijman, J. J., and Mestecky, J. (1984). Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J. Immunol. 132:16–18.PubMedGoogle Scholar
  27. Craig, S. W., and Cebra, J. (1971). Peyer’s patches: An enriched source of precursors for IgA producing immunocytes in the rabbit. J. Exp. Med. 134:188–200.PubMedGoogle Scholar
  28. Crowley-Nowick, P. A., Bell, M. C., Brockwell, R., Edwards, R. P., Chen, C., Partridge, E. E., and Mestecky, J. (1997). Rectal immunization for induction of specific antibody in the genital tract of women. J. Clin. Immunol. 17:370–379.PubMedGoogle Scholar
  29. Cunningham, A. L., and Mikloska, Z. (2001). The holy grail: Immune control of human herpes simplex virus infection and disease. Herpes 8(Suppl. 1):6A–10A.PubMedGoogle Scholar
  30. Cunningham, D. S. (1995). Immune response characteristics in women with chlamydial genital tract infection. Gynecol. Obstet. Invest. 39:54–59.PubMedGoogle Scholar
  31. Devito, C., Hinkula, J., Kaul, R., Lopalco, L., Bwayo, J. J., Plummer, F., Clerici, M., and Broliden, K. (2000). Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 14:1917–1920.PubMedGoogle Scholar
  32. Devito, C., Zuber, B., Schroder, U., Benthin, R., Okuda, K., Broliden, K., Wahren, B., and Hinkula, J. (2004). Intranasal HIV-1–gp160–DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity. J. Immunol. 173:7078–7089.PubMedGoogle Scholar
  33. Dorrell, L., Hessell, A. J., Wang, M., Whittle, H., Sabally, S., Rowland-Jones, S., Burton, D. R., and Parren, P. W. (2000). Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. AIDS 14:1117–1122.PubMedGoogle Scholar
  34. Fahey, J. V., Wallace, P. K., Johnson, K., Guyre, P. M., and Wira, C. R. (2006). Antigen presentation by human uterine epithelial cells to autologous T cells. Am. J. Reprod. Immunol. 55:1–11.PubMedGoogle Scholar
  35. Ferrantelli, F., and Ruprecht, R. M. (2002). Neutralizing antibodies against HIV: Back in the major leagues? Curr. Opin. Immunol. 14:495–502.PubMedGoogle Scholar
  36. Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., and St. Louis, M. E. (1997). Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337:1105–1111.PubMedGoogle Scholar
  37. Fotopoulos, G., Harari, A., Michetti, P., Trono, D., Pantaleo, G., and Kraehenbuhl, J. P. (2002). Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc. Natl. Acad. Sci. USA 99:9410–9414.PubMedGoogle Scholar
  38. Gallichan, W. S., Johnson, D. C., Graham, F. L., and Rosenthal, K. L. (1993). Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect. Dis. 168:622–629.PubMedGoogle Scholar
  39. Gallichan, W. S., and Rosenthal, K. L. (1995). Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 13:1589–1595.PubMedGoogle Scholar
  40. Gallichan, W. S., Woolstencroft, R. N., Guarasci, T., McCluskie, M. J., Davis, H. L., and Rosenthal, K. L. (2001). Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J. Immunol. 166:3451–3457.PubMedGoogle Scholar
  41. Gillgrass, A. E., Ashkar, A. A., Rosenthal, K. L., and Kaushic, C. (2003). Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 77:9845–9851.PubMedGoogle Scholar
  42. Gillgrass, A. E., Fernandez, S. A., Rosenthal, K. L., and Kaushic, C. (2005a). Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation. J. Virol. 79:3107–3116.PubMedGoogle Scholar
  43. Gillgrass, A. E., Tang, V. A., Towarnicki, K. M., Rosenthal, K. L., and Kaushic, C. (2005b). Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue. J. Virol. 79:3117–3126.PubMedGoogle Scholar
  44. Gravlee, L. C. (1969). Jet irrigation method for the diagnosis of endometrial carcinoma. Obstet. Gynecol. 34:168–172.PubMedGoogle Scholar
  45. Hasse, A. (2005). Perils at the mucosal front lines for HIV and SIV and their hosts. Nat. Rev. Immunol. 5:783–792.Google Scholar
  46. He, Q., Mitchell, A., Morcol, T., and Bell, S. J. (2002). Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2. Clin. Diagn. Lab. Immunol. 9:1021–1024.PubMedGoogle Scholar
  47. Head, J. R., and Gaede, S. D. (1986). Ia antigen expression in the rat uterus. J. Reprod. Immunol. 9:137–153.PubMedGoogle Scholar
  48. Hendrickson, B. A., Guo, J., Brown, I., Dennis, K., Marcellino, D., Hetzel, J., and Herold, B. C. (2000). Decreased vaginal disease in J-chain-deficient mice following herpes simplex type 2 genital infection. Virology 271:155–162.PubMedGoogle Scholar
  49. Hocini, H., and Bomsel, M. (1999). Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J. Infect. Dis. 179(Suppl. 3):S448–S453.PubMedGoogle Scholar
  50. Huang, Y. T., Wright, A., Gao, X., Kulick, L., Yan, H., and Lamm, M. E. (2005). Intraepithelial cell neutralization of HIV-1 replication by IgA. J. Immunol. 174:4828–4835.PubMedGoogle Scholar
  51. Hurlimann, J., Dayal, R., and Gloor, E. (1978). Immunoglobulins and secretory component in endometrium and cervix: Influence of inflammation and carcinoma. Virch. Arch. Path. Anat. Histol. 377:211–223.Google Scholar
  52. Israel, Z. R., Gettie, A., Ishizaka, S. T., Mishkin, E. M., Staas, J., Gilley, R., Montefiori, D., Marx, P. A., and Eldridge, J. H. (1999). Combined systemic and mucosal immunization with microsphere-encapsulated inactivated simian immunodeficiency virus elicits serum, vaginal, and tracheal antibody responses in female rhesus macaques. AIDS Res. Hum. Retroviruses 15:1121–1136.PubMedGoogle Scholar
  53. Johansson, E. L., Rudin, A., Wassen, L., and Holmgren, J. (1999). Distribution of lymphocytes and adhesion molecules in human cerrvix and vagina. Immunology 96:272–277.PubMedGoogle Scholar
  54. Johansson, M., Schon, K., Ward, M., and Lycke, N. (1997a). Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in n-interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 65:1032–1044.PubMedGoogle Scholar
  55. Johansson, M., Ward, M., and Lycke, N. (1997b). B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis. Immunology 92:422–428.PubMedGoogle Scholar
  56. Kamat, B. R., and Isaacson, P. G. (1987). The immunocytochemical distribution of leukocytic subpopulations in human endometrium. Am. J. Pathol. 127:66–73.PubMedGoogle Scholar
  57. Kantele, A., Hakkinen, M., Moldoveanu, Z., Lu, A., Savilahti, E., Alvarez, R. D., Michalek, S., and Mestecky, J. (1998). Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans. Infect. Immun. 66:5630–5635.PubMedGoogle Scholar
  58. Kaul, R., Rowland-Jones, S. L., Kimani, J., Fowke, K., Dong, T., Kiama, P., Rutherford, J., Njagi, E., Mwangi, F., Rostron, T., Onyango, J., Oyugi, J., MacDonald, K. S., Bwayo, J. J., and Plummer, F. A. (2001). New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol. Lett. 79:3–13.PubMedGoogle Scholar
  59. Kaul, R., Thottingal, P., Kimani, J., Kiama, P., Waigwa, C. W., Bwayo, J. J., Plummer, F. A., and Rowland-Jones, S. L. (2003). Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women. AIDS 17:1139–1144.PubMedGoogle Scholar
  60. Kaul, R., Trabattoni, D., Bwayo, J. J., Arienti, D., Zagliani, A., Mwangi, F. M., Kariuki, C., Ngugi, E. N., MacDonald, K. S., Ball, T. B., Clerici, M., and Plummer, F. A. (1999). HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 13:23–29.PubMedGoogle Scholar
  61. Kaushic, C., Ashkar, A. A., Reid, L. A., and Rosenthal, K. L. (2003). Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J. Virol. 77:4558–4565.PubMedGoogle Scholar
  62. Kaushic, C., Frauendorf, E., Rossoll, R. M., Richardson, J. M., and Wira, C. R. (1998). Influence of the estrous cycle on the presence and distribution of immune cells in the rat reproductive tract. Am. J. Reprod. Immunol. 39:209–216.PubMedGoogle Scholar
  63. Kaushic, C., Frauendorf, E., and Wira, C. R. (1997). Polymeric immunoglobulin A receptor in the rodent female reproductive tract: expression in vagina and tissue specific mRNA regulation by sex hormones. Biol. Reprod. 57:958–966.PubMedGoogle Scholar
  64. Kaushic, C., Murdin, A. D., Underdown, B. J., and Wira, C. R. (1998). Chlamydia trachomatis infection in the female reproductive tract of the rat: Influence of progesterone on infectivity and immune response. Infect. Immun. 66:893–898.PubMedGoogle Scholar
  65. Kaushic, C., Richardson, J. M., and Wira, C. R. (1995). Regulation of polymeric immunoglobulin A receptor messenger ribonucleic acid expression in rodent uteri: effect of sex hormones. Endocrinology 136:2836–2844.PubMedGoogle Scholar
  66. Kaushic, C., Zhou, F., Murdin, A. D., and Wira, C. R. (2000). Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 68:4207–4216.PubMedGoogle Scholar
  67. Kelly, J., and Fox, H. (1979). The local immunological defense system in the human endometrium. J. Reprod. Immunol. 1:39–45.PubMedGoogle Scholar
  68. Kerr, W. R. (1955). Vaginal and uterine antibodies in cattle with particular reference to Brucella abortus. Br. Vet. J. 111:169–178.Google Scholar
  69. Kett, K., Brandtzaeg, P., Radl, J., and Haaijman, J. J. (1986). Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J. Immunol. 136:3631–3635.PubMedGoogle Scholar
  70. Kozlowski, P. A., and Neutra, M. R. (2003). The role of mucosal immunity in prevention of HIV transmission. Curr. Mol. Med. 3:217–228.PubMedGoogle Scholar
  71. Kozlowski, P. A., Williams, S. B., Lynch, R. M., Flanigan, T. P., Patterson, R. R., Cu-Uvin, S. and Neutra, M. R. (2002). Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J. Immunol. 169:566–574.PubMedGoogle Scholar
  72. Kuklin, N., Daheshia, M., Karem, K., Manickan E., and Rouse, B. T. (1997). Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71:3138–3145.PubMedGoogle Scholar
  73. Kunkel, E., and Butcher, E. (2003). Plasma cell homing. Nat. Rev. Immunol. 3:822–829.PubMedGoogle Scholar
  74. Kutteh, W. H., Edwards, R. P., Menge, A. C., and Mestecky, J. (1993). IgA immunity in female reproductive tract secretions. In: Griffin, P. D., and Johnson, P. (eds.), Local Immunity in Reproductive Tract Tissues, Oxford University Press, New Delhi, pp. 229–243.Google Scholar
  75. Kutteh, W. H., Hatch, K. D., Blackwell, R. E., and Mestecky, J. (1988). Secretory immune system of the female reproductive tract. I. Immunoglobulin and secretory component-containing cells. Obstet. Gynecol. 71:56–60.PubMedGoogle Scholar
  76. Kutteh, W. H., and Mestecky, J. (1994). Secretory immunity in the female reproductive tract. Am. J. Reprod. Immunol. 31:40–46.PubMedGoogle Scholar
  77. Kutteh, W. H., Mestecky, J., and Wira, C. R. (2005). Mucosal immune system in the human female reproductive tract. In: Mestecky, J., Bienenstock, J., Lamm, M., Strober, W., McGhee, J., and Mayer, L. (eds.), Mucosal Immunology, 3rd ed., Academic Press, San Diego, pp. 1631–1646.Google Scholar
  78. Laguens, G., Goni, J. J., laguens, M.,. Goni, J. M., and Laguens, R. (1990). Demonstration and characterization of HLA-DR positive cells in the stroma of human endometrium. J. Reprod. Immunol. 18:179–186.PubMedGoogle Scholar
  79. Lavreys, L., Baeten, J. M., Martin, H. L., Jr., Overbaugh, J., Mandaliya, K., Ndinya-Achola, J., and Kreiss, J. K. (2004). Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS 18:695–697.PubMedGoogle Scholar
  80. Lazarus, N. H., Kunkel, E. J., Johnston, B., Wilson, E., Youngman, K. R., and Butcher, E. C. (2003). A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J. Immunol. 170:3799–3805.PubMedGoogle Scholar
  81. Liu, F., Bergami, P. L., Duval, M., Kuhrt, D., Posner, M., and Cavacini, L. (2003). Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120. AIDS Res. Hum. Retroviruses 19:597–607. MacPherson, A., Gatto, D., Sainsbury, E., Harriman, G., Hengartner, H., and Zinkernagel, R. M. (2000). A primitive T cell independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288:2222–2226.Google Scholar
  82. Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulligan, M. J., Yamshchikov, G. V., Chen, D., and Eldridge, J. H. (1993). Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323–1327.PubMedGoogle Scholar
  83. Marx, P. A, Spira, A. I., Gettie, A., Dailey, P. J., Veazey, R. S., Lackner, A. A., Mahoney, C. J., Miller, C. J., Claypool, L. E., Ho, D. D., and Alexander, N. J. (1996). Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 2:1084–1089.PubMedGoogle Scholar
  84. Mascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., Lu, Y., Robb, M. L., Katinger H., and Birx, D. L. (1999). Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol. 73:4009–4018.PubMedGoogle Scholar
  85. Mascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx D. L., and Lewis, M. G. (2000). Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:207–210.PubMedGoogle Scholar
  86. Mazanec, M. B., Coudret, C. L., and Fletcher, D. R. (1995). Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol. 69:1339–1343.PubMedGoogle Scholar
  87. Mazanec, M. B., Kaetzel, C. S., Lamm, M. E., Fletcher, D., and Nedrud, J. G. (1992). Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA 89:6901–6905.PubMedGoogle Scholar
  88. Mazanec, M. B., Nedrud, J. G., Kaetzel, C. S., and Lamm, M. E. (1993). A three-tiered view of the role of IgA in mucosal defense. Immunol. Today 14:430–435.PubMedGoogle Scholar
  89. Mazzoli, S., Lopalco, L. Salvi, A., Trabattoni, D., Lo Caputo, S., Semplici, F., Biasin, M., Blé, C., Cosma, A., Pastori, C., Meacci, F., Mazzotta, F., Villa, M. L., Siccardi, A. G., and Clerici, M. (1999). Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons. J. Infect. Dis. 180:871–875.PubMedGoogle Scholar
  90. Mazzoli, S., Trabattoni, D., Lo Caputo, S., Piconi, S., Blé, C., Meacci, F., Ruzzante, S., Salvi, A., Semplici, F., Longhi, R., Fusi, M. L., Tofani, N., Biasin, M., Villa, M. L., Mazzotta, F., and Clerici, M. (1997). HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3:1250–1257.PubMedGoogle Scholar
  91. Mbopi-Keou, F. X., Belec, L., Dalessio, J., Legoff, J., Gresenguet, G., Mayaud, P., Brown D. W., and Morrow, R. A. (2003). Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2. Clin. Diagn. Lab. Immunol. 10:388–393.PubMedGoogle Scholar
  92. McDermott, M. R., and Bienenstock, J. (1979). Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122:1892–1898.PubMedGoogle Scholar
  93. McDermott, M. R., Clark, D. A., and Bienenstock, J. (1980). Evidence for a common mucosal immunologic system. II. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J. Immunol. 124:2536–2539.PubMedGoogle Scholar
  94. Meng, G., Wei, X., Wu, X., Sellers, M. T., Decker, J. M., Moldoveanu, Z., Orenstein, J. M., Graham, M. F., Kappes, J. C., Mestecky, J., Shaw, G. M., and Smith, P. D. (2002). Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat. Med. 8:150–156.PubMedGoogle Scholar
  95. Menge, A. C., and Mestecky, J. (1993). Surface expression of secretory component and HLA class II DR antigen on glandular epithelial cells from human endometrium and two endometrial adenocarcinoma cell lines. J. Clin. Immunol. 13:259–264.PubMedGoogle Scholar
  96. Mestecky, J., and Fultz, P. (1999). Mucosal immune system of the human genital tract. J. Infect. Dis. 179(Suppl. 3):S470–S474.PubMedGoogle Scholar
  97. Mestecky, J., Jackson, S., Moldoveanu, Z., Nesbit, L. R., Kulhavy, R., Prince, S. J., Sabbaj, S., Mulligan, M. J., and Goepfert, P. A. (2004). Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS Res. Hum. Retroviruses 20:972–988.PubMedGoogle Scholar
  98. Mestecky, J., Bienenstock, J., Lamm, M., Strober, W., McGhee, J., and Mayer, L. (eds.). (2005a). Mucosal Immunology, 3rd ed., Academic Press, San Diego.Google Scholar
  99. Mestecky, J., Moldoveanu, Z., and Russell, M. W. (2005c). Immunologic uniqueness of the genital tract: challenge for vaccine development. Am. J. Reprod. Immunol. 53:208–214.PubMedGoogle Scholar
  100. Mestecky, J., Moro, I., Kerr, M. A., and Woof, J. M. (2005b). Mucosal immunoglobulins. In: Mestecky, J., Bienenstock, J., Lamm, M., Strober, W., McGhee, J., and Mayer, L. (eds.), Mucosal Immunology, 3rd ed., Academic Press, San Diego, pp. 153–181.Google Scholar
  101. Mestecky, J., and Russell, M. W. (2000). Induction of mucosal immune responses in the human genital tract. FEMS Immunol. Med. Microbiol. 27:351–355.PubMedGoogle Scholar
  102. Michetti, P., Mahan, M. J., Slauch, J. M., Mekalanos J. J., and Neutra, M. R. (1992). Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect. Immun. 60:1786–1792.PubMedGoogle Scholar
  103. Moldoveanu, Z., Huang, W. Q., Kulhavy, R., Pate, M. S., and Mestecky, J. (2005). Human male genital tract secretions: Both mucosal and systemic immune compartments contribute to the humoral immunity. J. Immunol. 175:4127–4136.PubMedGoogle Scholar
  104. Moja, P., Tranchat, C., Tchou, Pozzetto, B., Lucht, F., Dewsgranges, C., and Genin, C. (2000). Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients. J. Infect. Dis. 181:1607–1613.PubMedGoogle Scholar
  105. Morell, V. (1995). Attacking the causes of “silent” infertility. Science 269:775–777.PubMedGoogle Scholar
  106. Morrison, L. A., Da Costa, X. J., and Knipe, D. M. (1998). Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge. Virology 243:178–187.PubMedGoogle Scholar
  107. Morrison, R. P., Manning, D. S., and Caldwell, H. D. (1992). Immunology of Chlamydia trachomatis infections. In: Quinn, T. C. (ed.), Sexually Transmitted Diseases , Raven Press, New York, pp. 57–84.Google Scholar
  108. Morrison, S. G., and Morrison, R. P. (2005a). A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J. Immunol. 175:7536–7542.PubMedGoogle Scholar
  109. Morrison, S. G., and Morrison, R. P. (2005b). The protective effect of antibody in immunity to murine chlamydial genital tract reinfection is independent of immunoglobulin A. Infect. Immun. 73:6183–6186.PubMedGoogle Scholar
  110. Morrison, S. G., Su, H., Caldwell, H. D., and Morrison, R. P. (2000). Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect. Immun. 68:6979–6987.PubMedGoogle Scholar
  111. Morton, H. C., van Egmond, M., and van de Winkel, J. G. (1996). Structure and function of human IgA Fc receptors (FcaR). Crit. Rev. Immunol. 16:423–440.PubMedGoogle Scholar
  112. Mostad, S. B. (1998). Prevalence and correlates of HIV-1 shedding in female genital tract. AIDS Res. Hum. Retroviruses 14(Suppl. 1):S11–S15.PubMedGoogle Scholar
  113. Ochsenbein, A. F., Fehr, T., Lutz, C., Suter, M., Brombacher, F., Hengartner, H., and Zinkernagel, R. M. (1999). Control of early viral and bacterial distribution and disease by natural antibodies. Science 286:2156–2159.PubMedGoogle Scholar
  114. Ochsenbein, A. F., and Zinkernagel, R. M. (2000). Natural antibodies and complement link innate and acquired immunity. Immunol. Today 21:624–630.PubMedGoogle Scholar
  115. Ogra, P. L., and Ogra, S. S. (1973). Local antibody response to poliovaccine in the human female genital tract. J. Immunol. 110:1307–1311.PubMedGoogle Scholar
  116. Pal, S., Peterson, E. M., and de la Maza, L. M. (1996). Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge. Infect. Immun. 64:5341–5348.PubMedGoogle Scholar
  117. Parr, E. L., and Parr, M. B. (1988). Anti-bacterial IgA and IgG in mouse uterine luminal fluid, vaginal washings and serum. J. Reprod. Immunol. 13:65–72.PubMedGoogle Scholar
  118. Parr, E. L., and Parr, M. B. (1997). Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J Virol 71:8109–8115.PubMedGoogle Scholar
  119. Parr, E. L., Parr, M. B., and Thapar, M. (1988). A comparison of specific antibody responses in mouse vaginal fluid after immunization by several routes. J. Reprod. Immunol. 14:165–176.PubMedGoogle Scholar
  120. Parr, E. L., and Parr, M. B. (2005). Female genital tract infections and immunity in animal models. In: Mestecky, J., Bienenstock, J., Lamm, M., Strober, W., McGhee, J., and Mayer, L. (eds.). Mucosal Immunology, 3rd ed., Academic Press, San Diego, pp. 1613–1630.Google Scholar
  121. Parr, M. B., and Parr, E. L. (1989). Immunohistochemical investigation of secretory component and immunoglobulin A in the genital tract of the female rat. J. Reprod. Fertil. 85:105–113.PubMedGoogle Scholar
  122. Parr, M. B., and Parr, E. L. (1985). Immunohistochemical localization of immunoglobulins A, G and M in the mouse female genital tract. J. Reprod. Fertil. 74:361–370.PubMedGoogle Scholar
  123. Parr, M. B., and Parr, E. L. (1991). Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol. Reprod. 44:491–498.PubMedGoogle Scholar
  124. Parr, M. B., and Parr, E. L. (1996). Immunoglobulins in the female genital tract. In: Bronson, R. D., Alexander, N. J., Anderson, D. J., Branch, D. W., and Kutteh, W. H. (eds.), Reproductive Immunology, Blackwell Science, Cambridge, MA, pp. 275–308.Google Scholar
  125. Parr, M. B., and Parr, E. L. (1999). Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated HSV-2. Immunol. Today 98:639–645.Google Scholar
  126. Parr, M. B., and Parr, E. L. (2000). Immunity to vaginal herpes simplex virus-2 infection in B-cell knockout mice. Immunology 101:126–131.PubMedGoogle Scholar
  127. Parr, M. B., and Parr, E. L. (2003). Vaginal immunity in the HSV-2 mouse model. Int. Rev. Immunol. 22:43–63.PubMedGoogle Scholar
  128. Patton, D. L., and Lichtenwalner, A. B. (1998). Animal models for the study of chlamydial infections. In: Stephens, R. S., Byrne, G. I., Christiansen, G., Clarke, I. N., Groyston, J. T., Rank, R. G., Ridgway, G. L., Saikku, P., Schachter, J., and Stamm, W. E. (eds.), Chlamydial Infections, Proceedings of the 9th International Symposium on Human Chlamydial Infection, International Chlamydia Symposium, San Francisco, pp. 641–650.Google Scholar
  129. Patton, D. L., and Rank, R. G. (1992). Animal models for the study of pelvic inflammatory disease. In: Quinn, T. C. (ed.), Sexually Transmitted Diseases, Raven Press, New York, pp. 85–111.Google Scholar
  130. Pitman, R. S., and Blumberg, R. S. (2000). First line of defense: The role of the intestinal epithelium as an active component of the mucosal immune system. J. Gastroenterol. 35:805–814.PubMedGoogle Scholar
  131. Pudney, J., and Anderson, D. J. (1995). Immunobiology of the human penile urethra. Am. J. Pathol. 147:155–165.PubMedGoogle Scholar
  132. Pudney, J., Quayle, A. J., and Anderson, D. J. (2005). Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 73:1253–1263.PubMedGoogle Scholar
  133. Rachman, F., Casimiri, V., Psychoyos, A., and Bernard, O. (1983). Immunoglobulins in the mouse uterus during the oestrous cycle. J. Reprod. Fertil. 69:17–21.PubMedGoogle Scholar
  134. Rebello, R., Green, F. H., and Fox, H. (1975). A study of the secretory immune system of the female reproductive tract. Br. J. Obstet. Gynecol. 82:812–816.Google Scholar
  135. Renegar, K. B., Menge, A., and Mestecky, J. (2006). Influenza virus infection of the murine uterus: A new model for antiviral immunity in the female reproductive tract. Viral Immunol. 19:613–622.PubMedGoogle Scholar
  136. Russell, M. W., Lue, C., van den Wall Bake, A. W., Moldoveanu, Z., and Mestecky, J. (1992). Molecular heterogeneity of human IgA antibodies during an immune response. Clin. Exp. Immunol. 87:1–6.PubMedGoogle Scholar
  137. Russell, M. W., and Mestecky, J. (2002). Humoral immune responses to microbial infections in the genital tract. Microbes Infect. 4:667–677.PubMedGoogle Scholar
  138. Russell, M. W., Moldoveanu, Z., White, P. L., Sibert, G. J., Mestecky, J., and Michalek, S. M. (1996). Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Infect. Immun. 64:1272–1283.PubMedGoogle Scholar
  139. Russell, M. W., Sparling, P., Morrison, R. P., Cauci, S., Fidel, P., Martin, D., Hook E., and Mestecky, J. (2005). Mucosal immunology of sexually transmitted diseases. In: Mestecky, J., Bienenstock, J., Lamm, M., Strober, W., McGhee, J., and Mayer, L. (eds.). Mucosal Immunology, 3rd ed., Academic Press, San Diego, pp. 1693–1720.Google Scholar
  140. Sansonetti, P. J. (2004). War and peace at mucosal surfaces. Nat. Rev. Immunol. 4:953–964.PubMedGoogle Scholar
  141. Schachter, J. (1989). Pathogenesis of chlamydial infections. 8:206–220.Google Scholar
  142. Schachter, J., and Grayston, J. T. (1998). Epidemiology of human chlamydial infections. In: Stephens, R. S., Byrne, G. I., Christiansen, G., Clarke, I. N., Groyston, J. T., Rank, R. G., Ridgway, G. L., Saikku, P., Schachter, J., and Stamm, W. E. (eds.), Chlamydial Infections, Proceedings of the 9th International Symposium on Human Chlamydial Infection, International Chlamydia Symposium, San Francisco, pp. 3–10.Google Scholar
  143. Schumacher, G. (1988). Immunology of spermatozoa and cervical mucus. Hum. Reprod. 3:289–300.PubMedGoogle Scholar
  144. Schumacher, G., Kim, M. H., Hossenianan, A., and Dupon, C. (1977). Immunoglobulins, proteinase inhibitors, albumin, and lysozyme in human cervical mucus. Am. J. Obstet. Gynecol. 129:629–636.PubMedGoogle Scholar
  145. Schumacher, G. F. B. (1980). Humoral immune factors in the female reproductive tract and their changes during the cycle. In: Dinsda, D., and Schumacher, G. (eds.), Immunological Aspects of Infertility and Fertility Control, Elsevier, New York, pp. 93–141.Google Scholar
  146. Senior, B. W., Dunlop, J. I., Batten, M. R., Kilian, M., and Woof, J. M. (2000). Cleavage of a recombinant human immunoglobulin A2 (IgA2)–IgA1 hybrid antibody by certain bacterial IgA1 proteases. Infect. Immun. 68:463–469.PubMedGoogle Scholar
  147. Shattock, R., and Moore, J. (2003). Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 1:25–34.PubMedGoogle Scholar
  148. Smith, S. M., Baskin, G. B., and Marx, P. A. (2000). Estrogen protects against vaginal transmission of simian immunodeficiency virus. J. Infect. Dis. 182:708–715.PubMedGoogle Scholar
  149. Stagg, A. J. (1998). Vaccines against Chlamydia: approaches and progress. Mol. Med. Today 4:166–173.PubMedGoogle Scholar
  150. Stubbe, H., Berdoz, J., Kraehenbuhl, J. P., and B. Corthésy (2000). Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J. Immunol. 164:1952–1960.PubMedGoogle Scholar
  151. Su, H., Feilzer, K., Caldwell, H. D., and Morrison, R. P. (1997). Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65:1993–1999.PubMedGoogle Scholar
  152. Sullivan, D. A., Richardson, G. S., MacLaughlin, D. T., and Wira, C. R. (1984). Variations in the levels of secretory component in human uterine fluid during the menstrual cycle. J. Steroid Biochem. 20:509–513.PubMedGoogle Scholar
  153. Sullivan, D. A., Underdown, B. J., and Wira, C. R. (1983). Steroid hormone regulation of free secretory component in the rat uterus. Immunology 49:379–386.PubMedGoogle Scholar
  154. Sullivan, D. A., and Wira, C. R. (1981). Estradiol regulation of secretory component in the female reproductive tract. J. Steroid Biochem. 15:439–444.PubMedGoogle Scholar
  155. Sullivan, D. A., and Wira, C. R. (1983). Hormonal regulation of immunoglobulins in the rat uterus: Uterine response to a single estradiol treatment. Endocrinology 112:260–268.PubMedGoogle Scholar
  156. Sullivan, D. A., and Wira, C. R. (1984). Hormonal regulation of immunoglobulins in the rat uterus: Uterine response to multiple estradiol treatments. Endocrinology 114:650–658.PubMedGoogle Scholar
  157. Sylvan, P. E., MacLaughlin, D. T., Richardson, G. S., Scully, R. E., and Nikrui, N. (1981). Human uterine fluid proteins associated with secretory phase endometrium: Progesterone-induced proteins? Biol. Reprod. 24:423–429.PubMedGoogle Scholar
  158. Tauber, P. F., Wettich, W., Nohlen, M., and Zaneveld, L. J. D. (1985). Diffusible proteins of the mucosa of the human cervix, uterus, and fallopian tubes: Distribution and variations during the menstrual cycle. Am. J. Obstet. Gynecol. 15:1115–1125.Google Scholar
  159. Tourville, D. R., Ogra, S., Lippes, J., and Tomsi, T. (1970). The human female reproductive tract: Immunohistochemical localization of TA, AG, GM, secretory piece and lactoferrin. Am. J. Obstet. Gynecol. 108:1102–1108.PubMedGoogle Scholar
  160. UNAIDS 2004 Report on HIV/AIDS Epidemic-July (2004). UNAIDS, Geneva, Switzerland.Google Scholar
  161. Vaerman, J.-P., and Férin, J. (1974). Local immunological response in the vagina, cervix and endometrium. Acta Endocrinol. 194:281–305.Google Scholar
  162. Vaerman, J.-P., and Férin, J. (1975). Local immunological response in vagina, cervix and endometrium. Acta Endocrinol. 194(Suppl.):281–305.Google Scholar
  163. van Egmond, M., Damen, C. A., van Spriel, A. B., Vidarsson, G., van Garderen, E., and van de Winkel, J. G. (2001). IgA and the IgA Fc receptor. Trends Immunol. 22:205–211.PubMedGoogle Scholar
  164. van Rompay, K. K., Berardi, C. J., Dillard-Telm, S., Tarara, R. P., Canfield, D. R., Valverde, C. R., Montefiori, D. C., Cole, K. S., Montelaro, R. C., Miller, C. J., and Marthas, M. L. (1998). Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J. Infect. Dis. 177:1247–1259.PubMedGoogle Scholar
  165. Waldmann, R., Cruz, J., and Rowe, D. (1971). Immunoglobulin levels to Candida albicans in human cervicovaginal secretions. Clin. Exp. Immunol. 9:427–434.Google Scholar
  166. Wang, C. C., McClelland, R. S., Overbaugh, J., Reilly, M., Panteleeff, D. D., Mandaliya, K., Chohan, B., Lavreys, L., Ndinya-Achola, J., and Kreiss, J. K. (2004). The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 18:205–209.PubMedGoogle Scholar
  167. Wira, C. R., Crane-Godreau, M. A., and Grant-Tschudy, K. S. (2005a). Endocrine regulation of the mucosal immune system in the female reproductive tract. In: Mestecky, J., Bienenstock, J., Lamm, M., Strober, W., McGhee, J., and Mayer, L. (eds.), Mucosal Immunology, 3rd ed., Academic Press, San Diego, pp. 1661–1678.Google Scholar
  168. Wira, C. R., Grant-Tschudy, K. S., and Crane-Godreau, M. A. (2005b). Epithelial cells in the female reproductive tract: A central role as sentinels of immune protection. Am. J. Reprod. Immunol. 53:65–76.PubMedGoogle Scholar
  169. Wira, C. R., and Merritt, K. (1977). Effect of the estrous cycle, castration and pseudopregnancy on E. coli in the uterus and uterine secretions of the rat. Biol. Reprod. 17:519–522.PubMedGoogle Scholar
  170. Wira, C. R., and Prabhala, R. H. (1993). The female reproductive tract is an inductive site for immune responses: Effect of estradiol and antigen on antibody and secretory component levels in uterine and cervico-vaginal secretions following various routes of immunization. In: Griffin, P. D., and Johnson, P. M. (eds.), Scientific Basis of Fertility Regulation. Local Immunity in Reproductive Tract Tissues, Oxford University Press, New York, pp. 271–293.Google Scholar
  171. Wira, C. R., and Sandoe, C. P. (1980). Hormone regulation of immunoglobulins: Influence of estradiol on IgA and IgG in the rat uterus. Endocrinology 106:1020–1026.PubMedGoogle Scholar
  172. Wira, C. R., and Sandoe, C. P. (1987). Specific IgA and IgG antibodies in the secretions of the female reproductive tract: Effects of immunization and estradiol on expression of this response in vivo. J. Immunol. 138:159–164.Google Scholar
  173. Wira, C. R., and Sandoe, C. P. (1989). Effect of uterine immunization and oestradiol on specific IgA and IgG antibodies in uterine, vaginal and salivary secretions. Immunology 68:24–30.PubMedGoogle Scholar
  174. Wira, C. R., Stern, J. E., and Colby, E. (1984). Estradiol regulation of secretory component in the uterus of the rat: evidence for involvement of RNA synthesis. J. Immunol. 133:2624–2628.PubMedGoogle Scholar
  175. Wira, C. R., and Sullivan, D. A. (1985). Estradiol and progesterone regulation of IgA, IgG and secretory component in cervico-vaginal secretions of the rat. Biol. Reprod. 32:90–95.PubMedGoogle Scholar
  176. Wolbank, S., Kunert, R., Stiegler, G., and Katinger, H. (2003). Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12. J. Virol. 77:4095–4103.PubMedGoogle Scholar
  177. Woof, J. M., and Kerr, M. A. (2006). The function of immunoglobulin A in immunity. J. Pathol. 208:270–82.PubMedGoogle Scholar
  178. Woof, J. M., and Mestecky, J. (2005). Mucosal immunoglobulins. Immunol. Rev. 206:64–82.PubMedGoogle Scholar
  179. Wright, P. F., Kozlowski, P. A., Rybczyk, G. K., Goepfert, P., Staats, H. F., VanCott, T. C., Trabattoni, D., Sannella, E., and Mestecky, J. (2002). Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res. Hum. Retroviruses 18:1291–1300.PubMedGoogle Scholar
  180. Wright, A., Yan, H., Lamm, M. E., and Huang, Y. T. (2006). Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells. Virology 356:165–170.PubMedGoogle Scholar
  181. Yang, S. L,. and Schumacher, G. F. B. (1979). Immune response after vaginal application of antigens in the rhesus monkey. Fertil. Steril. 32:588–598.PubMedGoogle Scholar
  182. Yeaman, G. R., Collins, J. E., Fanger, M. W., Wira, C. R., and Lydyard, P. M. (2001). CD8+ T cells in human uterine endometrial lymphoid aggregates: Evidence for accumulation of cells by trafficking. Immunology 102:434–440.PubMedGoogle Scholar
  183. Yeaman, G. R., Guyre, P. M., Fanger, M. W., Collins, J. E., White, H. D., Rathbun, W., Orndorff, K. A., Gonzalez, J., Stern, J. E., and Wira, C. R. (1997). Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J. Leuk. Biol. 61:427–435.Google Scholar
  184. Zhao, X., Deak, E., Soderberg, K., Linehan, M., Spezzano, D., Zhu, J., Knipe, D. M., and Iwasaki, A. (2003). Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197:153–162.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Charu Kaushic
    • 1
  • Charles R. Wira
    • 2
  1. 1.Department of Pathology and Molecular MedicineMcMaster UniversityHamiltonCanada
  2. 2.Department of PhysiologyDartmouth Medical SchoolLebanonUSA

Personalised recommendations